Skip to main content
The Markets by Proactive
Go to Proactive UK
Proactive UK has moved. Proactive’s coverage of London’s small caps continues on proactiveinvestors.com Go there →
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Coverage of London’s small caps continues on proactiveinvestors.com
Go to Proactive UK
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK

Archive

Football tournament snacking lifts blue chip stocks

Football tournament snacking lifts blue chip stocks

The FTSE 100 rallied again as UK retail sales came in much better than expected and US indices pushed on higher towards new records. London’s blue-chip index was 42 points up at 7,012 in early trading. People tucking into snacks as they watched the Euros football tournament helped retail sales rise by 0.5% in June, said the ONS. It followed a weak number in May but food sales jumped by 4.2% this time.

Ultra Electronics (LSE:ULE) (LSE:ULE) has received a non-binding takeover approach from aerospace group Cobham valuing the defence business at just under £2.6bn. Cobham is offering shareholders 3,500p per share in cash plus an interim dividend.

US-listed Snap Inc (NYSE:SNAP) shares surged in after-hours trading overnight after the disappearing messages app reported revenues more than doubled in its second quarter. Earnings also blew past analyst estimates for the period.

Alliance Trust (LSE:ATST) PLC is to exclude stocks with significant exposure to thermal coal and tar sands from its portfolio. The switch will not result in significant divestments, said the old-school investment trust.

Record PLC (LSE:REC) (LSE:REC), the specialist currency and derivatives group, saw assets under management grow 5% in the April-June quarter to US$84.5bn. Net inflows during what is its first quarter totalled US$1.8bn.

Oncimmune Holdings PLC (AIM:ONC, FRA:OCY) (AIM:ONC, FRA:OCY) (LON:ONC) has signed a profiling contract with a world-renowned cancer centre in the United States. The Dana-Farber Cancer Institute will use Oncimmune’s SeroTag technology to assess for resistance to checkpoint inhibitor drugs and chemotherapy.

Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK